Revision: May 30, 2019, 11:12 a.m.
HB 627 - AS AMENDED BY THE SENATE
27Feb2019... 0396h
05/30/2019 2211s
2019 SESSION
19-0712
10/01
HOUSE BILL 627
AN ACT relative to exceptions from certain pharmacy requirements for veterinarians.
SPONSORS: Rep. Long, Hills. 10
COMMITTEE: Executive Departments and Administration
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill requires the board of pharmacy to adopt rules on exceptions from compliance with the United States Pharmacopeia for practice by veterinarians.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
27Feb2019... 0396h
05/30/2019 2211s 19-0712
10/01
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
AN ACT relative to exceptions from certain pharmacy requirements for veterinarians.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Pharmacy; Compounding; Exception for Veterinarians. Amend RSA 318:14-a, I to read as follows:
I. Products that are not commercially available may be compounded for hospital or office use but shall not be resold or dispensed. Nonprescription items may be compounded upon order by a practitioner for sale as long as the labeling complies with RSA 318:47-a and the product is not a copy of, or similar to, prescription or nonprescription products. Except as provided in rules adopted under paragraph V for veterinarians, all compounding shall be done in compliance with the United States Pharmacopeia as defined by board of pharmacy rules.
2 Compounding; Rulemaking. Amend RSA 318:14-a, V to read as follows:
V. The board shall adopt rules under RSA 541-A concerning the regulation of compounding, including exceptions for veterinarians from compliance with the United States Pharmacopoeia Chapter 797.
3 Effective Date. This act shall take effect 60 days after its passage.